Medtronic PLC closed 14.24% short of its 52-week high of $96.25, which the company reached on March 10th.

Medtronic (NYSE:MDT) has appointed a former Dexcom leader as the new head of Americas for its Diabetes business unit.

Medtronic (NYSE: MDT) stock was a fairly hot item as the trading week kicked off, with investors pushing the shares up by ...

Medtronic's stock has lost around a third of its value since late 2022. However, stock prices for longtime dividend growers ...

A fired Medtronic USA Inc. senior director is unable to sue the company for disability discrimination under Minnesota law ...

Medtronic’s latest recall of the Pipeline Vantage 027 and 021 products is likely to result in revenue losses in the ...

Medtronic has inked a neurovascular partnership with Methinks AI, a Barcelona, Spain-based developer of programs to detect ...

Medtronic has issued a recall for several aortic root cannula devices due to a potential safety risk that could cause loose ...

KIMS Sunshine Hospital partners with Medtronic to establish renal denervation therapy centre for hypertension treatment.

Medtronic says its Evolut TAVR shows strong valve performance and durable outcomes at 5 years in low-risk aortic stenosis ...

Medtronic, Abbott and Boston Scientific had updates on their devices used in heart valve disease treatment at the event.

Medtronic PLC closed 14.93% below its 52-week high of $96.25, which the company reached on March 10th.